Tag Archives: MRI

PLEGRIDY? (PEGINTERFERON BETA-1A) TWO-YEAR DATA CONFIRM MAINTENANCE OF EFFICACY AND SAFETY IN MULTIPLE SCLEROSIS PATIENTS

PLEGRIDY? (PEGINTERFERON BETA-1A) TWO-YEAR DATA CONFIRM MAINTENANCE OF EFFICACY AND SAFETY IN MULTIPLE SCLEROSIS PATIENTS

CAMBRIDGE, Mass. ? Sept. 11, 2014 ? Today Biogen Idec (NASDAQ: BIIB) announced new data from the second year of its Phase 3 ADVANCE clinical trial that show the positive treatment effects of PLEGRIDY? (peginterferon beta-1a) were maintained in people with relapsing forms of multiple sclerosis (RMS) beyond the first year of the study.…

NEW TYSABRI? DATA SHOW EARLIER TREATMENT AND LONGER-TERM USE RESULT IN SIGNIFICANT REDUCTIONS IN MS DISEASE ACTIVITY

? WESTON, Mass. ? Oct. 3, 2013 ? Biogen Idec (NASDAQ: BIIB) today announced results from several new analyses of TYSABRI? (natalizumab) data that demonstrate its effectiveness in reducing multiple sclerosis (MS) disease activity. This effect was particularly significant in people with relapsing MS who initiated treatment when they had lower Expanded Disability Status Scale (EDSS) scores as well as in those who have been treated for more than two years.…

Elekta and Philips research consortium on MRI-guided radiation therapy adds The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital

Dutch clinic joins group dedicated to developing next-generation radiotherapy innovation for treatment of cancer patients Amsterdam, the Netherlands ? Elekta (NSE: EKTAb) and Royal Philips Electronics (NYSE: PHG, AEX: PHIA) announced today that The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL, Amsterdam, the Netherlands) has signed an agreement to join a research group to advance the development of ground-breaking image-guided treatment technology for cancer care.…

Elekta och Philips i forskningssamarbete för att skapa banbrytande cancerv?rd genom integrering av linjäraccelerator och magnetresonansavbildning

Kombinationen av str?lbehandling och samtidig magnetresonansavbildning (MRI) är nästa generations innovation för behandling av cancerpatienter Stockholm och Amsterdam, 25 oktober, 2012 ? Elekta AB (NSE: EKTAb) och Royal Philips Electronics (NYSE: PHG, AEX: PHIA) meddelar att de bygger vidare p? sitt gemensamma program för att n?…
Top